Add BrightSurf on Google Email

Science News for March 22, 2015


Apple MacBook Pro 14-inch (M4 Pro)

Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.

Rush to crush risks medicine effectiveness

A study by Queensland University of Technology found that almost half of respondents modified medication dosage forms without seeking advice from healthcare professionals. The research highlights the potential dangers of crushing tablets or modifying capsules, which can lead to reduced effectiveness and increased risk of adverse effects.

SourceQueensland University of Technology·JournalJournal of Pharmacy Practice and Research·DateMar 22, 2015

Special microbes make anti-obesity molecule in the gut

Researchers have programmed bacteria to generate a hunger-suppressing lipid, leading to reduced body fat and staved-off diabetes in mice. The therapeutic bacteria could provide sustained drug delivery, potentially improving weight loss outcomes for humans.

SourceAmerican Chemical Society·DateMar 22, 2015
Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C)

Anker Laptop Power Bank 25,000mAh (Triple 100W USB-C) keeps Macs, tablets, and meters powered during extended observing runs and remote surveys.

Air pollutants could boost potency of common airborne allergens

Researchers find that nitrogen dioxide and ground-level ozone can increase the potency of airborne allergens, contributing to rising allergy rates. The study suggests chemical modifications of allergenic proteins may play a key role in the increasing prevalence of allergies worldwide.

SourceAmerican Chemical Society·DateMar 22, 2015

New potential for personalized treatments in bowel cancer

Research links genetic changes in bowel tumours to immune system responses, suggesting potential for targeted immunotherapy treatments. Genetic profiles could be used to diagnose suitability for immunotherapies and tailor treatment plans.

SourceCancer Research UK·JournalOncoImmunology·DateMar 22, 2015

Blood test for patients on acne medication deemed unnecessary

A study by Brigham and Women's Hospital found that routine potassium monitoring for healthy women taking spironolactone for acne does not change the course of treatment, but cumulatively costs $80,000. The researchers suggest ending routine testing to improve patient care experience and reduce healthcare spending.

SourceBrigham and Women's Hospital·JournalJAMA Dermatology·DateMar 22, 2015
Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.